Scopio Labs

Scopio Labs is a medical technology company revolutionizing hematology diagnostics through its innovative use of computational photography and AI. Their Full-Field Morphology platform provides high-resolution, digital images of blood samples, enabling faster, more accurate, and efficient analysis compared to traditional microscopy. Scopio Labs’ products are designed to address challenges faced by hematology laboratories, including increasing test volumes, complex cases, and staffing shortages.

The company’s mission is to improve patient outcomes by expediting access to life-saving treatments. Their AI-powered decision support system provides insights and interpretations to aid in diagnosing and classifying blood disorders. Scopio Labs has gained FDA clearance for its products, showcasing their commitment to quality and safety. They are actively collaborating with industry partners and researchers to continue pushing the boundaries of digital hematopathology and shape the future of disease detection and diagnosis.

Scopio Labs is revolutionizing first-line diagnostic testing in hematology by leveraging computational photography and AI to image and analyze cell morphology at an unprecedented scale. Their mission is to transform the way healthcare professionals see, work, and diagnose, ultimately expediting access to life-saving treatments and improving patient outcomes.

Scopio Labs fosters a culture of innovation and collaboration, driven by a shared passion for revolutionizing healthcare through technology. The company values the diverse expertise of its team, encouraging open communication, creative problem-solving, and a willingness to push boundaries. With a focus on developing life-saving solutions, Scopio Labs cultivates an environment where employees feel empowered to contribute their skills and ideas, ultimately aiming to improve patient outcomes and the future of disease detection.